...and how will the statistical significance look if the near 90% vs 50% healing at 10 weeks carried across 30 patients? 0.05 P-value anyone? If that the case you will be around 95% confident that CYP will outperform SOC.
These results were only ever initial results, nothing more,, and are undeniably a good insight into the possible outcome in the full 30 patients, of which 25 already recruited, which will be statistically significant if repeated across the full population.
Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 16.0¢ | $10.82K | 65.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4450 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 88474 | 2 |
View Market Depth
| Last trade - 15.32pm 20/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |